Active substanceMesodiethylethylene dibenzenesulfonateMesodiethylethylene dibenzenesulfonate Similar drugsTo uncover Sagenite® capsules inwards NIZHFARM, JSC Russia Sagenite® pills inwards NIZHFARM, JSC Russia Dosage form: & nbspcapsules. Composition:One capsule contains:active substance: mesodiethylethylenedibenzenesulfonate dicalcium dihydrate (sygetin) - 100 mg;Excipients: sucrose (sugar); potato starch, stearic acid. Capsules hard gelatinous. The composition of the capsule shell: indigocarmine, yellow quinoline dye, titanium dioxide, gelatin. Description:Capsules number 1, the body is white and the lid is green. The contents of capsules are white or almost white. Pharmacotherapeutic group:antiplasmic remedy. ATX: & nbspG.02.C.X Other drugs for use in gynecology Pharmacodynamics:Participates in the implementation of positive and negative feedback in the hypothalamic-pituitary-ovarian system, has a stabilizing effect on the gonadotropic function of the pituitary and hypothalamic center, without having an estrogenic effect on the target organs; strengthens uterine contractions; increases placental blood flow; helps increase the concentration in the blood of beta-lipoproteins, increase the sensitivity of tissues to the action of insulin and the utilization of glucose. Indications:Climacteric syndrome (manifested by "hot flashes", increased sweating, sleep disorders, irritability, depression, forgetfulness, degenerative changes in the skin and mucous membranes - fragility of the nails, thinning of the skin, wrinkles, dystrophy of the urinary tract mucosa). Contraindications: Hypersensitivity, metrorrhagia. Carefully:Renal failure, impaired liver function, hyperlipoproteinemia. Pregnancy and lactation: During pregnancy and lactation is not applied. Dosing and Administration:Take inside, regardless of the time of ingestion, with menopausal disorders in women 1 capsule per day. Daily dose - up to 2 capsules a day. The course of treatment is 30-40 days. Side effects:In rare cases, nausea, vomiting, dizziness, allergic reactions (rashes, swelling of the eyelids) are possible; metrorrhagia, cholestatic jaundice. Overdose:Symptoms: metrorrhagia, hemorrhagic shock.Treatment: withdrawal of the drug, blood transfusion, parenteral administration of blood substitutes. Interaction:Strengthens the action of diuretic, antiarrhythmic, antihypertensive drugs, anticoagulants.Weakens the effects of male sex hormones.Folic acid and thyroid drugs increase the effectiveness of Sagenite®. Special instructions:When assigning Sagenite® to patients with diabetes mellitus, it should be taken into account that 1 capsule contains 0.05 g of sucrose. Form release / dosage:Sagenite® capsules 100 mg.10 capsules in a planar cell package. One or three contour packagings together with instructions for medical use of the drug are placed in a pack of cardboard. Storage conditions:List B. In a dry place at a temperature of no higher than 25 ° C. Keep out of the reach of children. Shelf life:3 years. Do not use after the expiration date. Terms of leave from pharmacies:On prescription Registration number:LSR-000761/10 Date of registration:05.02.2010 The owner of the registration certificate:NIZHFARM, JSC NIZHFARM, JSC Russia Representation: & nbspNizhpharm, JSCNizhpharm, JSCRussia Information update date: & nbsp03.08.2015 Illustrated instructions × Illustrated instructions Instructions